(Q38190418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

review article

1 reference

title

Role of microRNAs in malignant mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Simona Coco

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Angela Alama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Carlo Genova

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Francesco Grossi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Francesco Grossi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

C Sini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M G Dal Bello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

G Barletta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

E Rijavec

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

G Burrafato

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

F Boccardo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

23 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

2865-2878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

Asbestos and cancer: An overview of current trends in Europe

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The pathogenesis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Current concepts in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Surgical therapy of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Surgical treatment of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Chemotherapy and radiotherapy for mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Early stages of mesothelioma, screening and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Prediction and validation of microRNAs and their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Molecular changes in mesothelioma with an impact on prognosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNAs accurately identify cancer tissue origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Serum microRNAs are promising novel biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The MicroRNA Spectrum in 12 Body Fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Analysis of circulating microRNA: preanalytical and analytical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNAs and cancer: towards a personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNA classifiers for predicting prognosis of squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Profiling microRNA expression with microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNAs dysregulation in human malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Genomic events associated with progression of pleural malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Pro-tumorigenic effects of miR-31 loss in mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Onconase mediated NFKβ downregulation in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

miR-1 induces growth arrest and apoptosis in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1584-5

Malignant pleural mesothelioma: a comprehensive review

21 January 2018

1 reference

12 December 2020

Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells

1 reference

12 December 2020

[microRNAs as biological indicators of environmental and occupational exposure to asbestos].

1 reference

12 December 2020

Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients

1 reference

12 December 2020

Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?

1 reference

12 December 2020

Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma

1 reference

12 December 2020

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

1 reference

12 December 2020

MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells

1 reference

12 December 2020

Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer

1 reference

12 December 2020

Malignant mesothelioma of the pleural space

1 reference

12 December 2020

A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

12 December 2020

Systematic review of trimodality therapy for patients with malignant pleural mesothelioma

1 reference

12 December 2020

Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health

1 reference

12 December 2020

Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma

1 reference

12 December 2020

MicroRNAs as Novel Biomarkers for Breast Cancer

1 reference

12 December 2020

Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province

1 reference

12 December 2020

Peritoneal mesothelioma: a review

1 reference

12 December 2020

Malignant mesothelioma

1 reference

12 December 2020

10.1007/S00018-014-1584-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json

release_3dufez4kx5fytnet42ncbxhhkq

8 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3dufez4kx5fytnet42ncbxhhkq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24562347%20AND%20SRC:MED&resulttype=core&format=json